Efficacy and safety of dostarlimab in UK-specific patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) or DNA polymerase epsilon, catalytic subunit (POLε)-mutated solid tumours in the GARNET study

被引：1

作者：

Samuel, L.

Miller, R.

Ross, P.

Arkenau, T. ^{[1
]}

Antony, G. ^{[2
]}

Veneris, J.

Rule, J. ^{[2
]}

Starling, N. ^{[3
]}

机构：

[1] Sarah Cannon Res Inst, London, England

[2] GlaxoSmithKline, London, England

[3] Royal Marsden, London, England

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

基金：

芬兰科学院;

关键词：

D O I：

10.1016/j.annonc.2023.04.220

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-164

引用

页码：S73 / S74

页数：2

共 50 条

[21] PEMBROLIZUMAB MONOTHERAPY FOR MICROSATELLITE INSTABILITY-HIGH (MSI-H) OR MISMATCH REPAIR DEFICIENT (DMMR) RECURRENT GLIOMAS: RESULTS FROM THE MULTICOHORT PHASE 2 KEYNOTE-158 STUDY [J].

Baldini, Capucine ;

Cassier, Philippe A. ;

Delord, Jean-Pierre ;

Simonelli, Matteo ;

Touat, Mehdi ;

Yao, Lili ;

Duic, J. Paul ;

Gozman, Alexander ;

Marabelle, Aurelien .

NEURO-ONCOLOGY, 2022, 24 :59-60

[22] Progression-free survival (PFS) and overall survival (OS) in advanced/recurrent (AR) mismatch repair deficient/microsatellite instability-high or proficient/stable (dMMR/MSI-H or MMRp/MSS) endometrial cancer (EC) treated with dostarlimab in the GARNET study [J].

Tinker, A. V. ;

Pothuri, B. ;

Gilbert, L. ;

Sabatier, R. ;

Brown, J. ;

Ghamande, S. ;

Mathews, C. ;

O'Malley, D. ;

Boni, V. ;

Gravina, A. ;

Banerjee, S. ;

Miller, R. ;

Pikiel, J. ;

Mirza, M. R. ;

Duan, T. ;

Antony, G. ;

Zildjian, S. ;

Zografos, E. ;

Veneris, J. ;

Oaknin, A. .

ANNALS OF ONCOLOGY, 2022, 33 (07) :S798-S799

[23] FREQUENCY OF AND TESTING PATTERNS FOR MICROSATELLITE INSTABILITY HIGH (MSI-H) AND DEFICIENT MISMATCH REPAIR (DMMR) AMONG SOLID TUMORS IN A US COMMUNITY ONCOLOGY SETTING [J].

Chase, M. ;

Vasudevan, A. ;

Amonkar, M. ;

Myer, N. ;

Wang, T. ;

Prabhu, V ;

Turzhitsky, V ;

Spira, A. .

VALUE IN HEALTH, 2022, 25 (07) :S452-S452

[24] Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) stage IV colorectal cancer (CRC) [J].

Andre, Thierry ;

Sposetti, Caterina ;

Gumus, Mahmut ;

Ahn, Joong Bae ;

Wyrwicz, Lucjan ;

Kwiatkowski, Mariusz ;

Kim, Jong Gwang ;

Yalcin, Suayib ;

Sendur, Mehmet A. N. ;

Odeleye-Ajakaye, Amos ;

Leconte, Pierre ;

Fogelman, David R. ;

Kim, Tae Won .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

[25] Retifanlimab in patients with recurrent microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) endometrial cancer: Final results from the POD1UM-101 study (Cohort H) [J].

Berton-Rigaud, D. ;

Pautier, P. ;

Lorusso, D. ;

Gennigens, C. ;

Gladieff, L. ;

Kryzhanivska, A. ;

Bowman, J. ;

Tian, C. ;

Cornfeld, M. ;

Van Gorp, T. .

ANNALS OF ONCOLOGY, 2023, 34 :S517-S517

[26] Neoadjuvant nivolumab plus ipilimumab in microsatellite instability-high (MSI-H)/deficient mismatch repair (dMMR) rectal tumors: ECOG-ACRIN EA2201 [J].

Ciombor, K. K. ;

Hong, S. ;

Eng, C. ;

Yao, X. ;

You, N. ;

Das, P. ;

Chakravarthy, A. ;

O'Dwyer, P. J. .

ANNALS OF ONCOLOGY, 2024, 35 :S104-S104

[27] An unusual case of microsatellite instability-high/deficient mismatch repair (MSI-H/dMMR) diffuse large B-cell lymphoma revealed by targeted gene sequencing [J].

Han, Bogyeong ;

Kim, Sehui ;

Koh, Jiwon ;

Bae, Jeong Mo ;

Yun, Hongseok ;

Jeon, Yoon Kyung .

JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2022, 56 (02) :92-96

[28] Initial findings from the DREAM-GI national database: Assessing the efficacy and safety of neoadjuvant immunotherapy (NIT) in patients with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) gastrointestinal (GI) cancer. [J].

Chakrabarti, Sakti ;

Selfridge, J. Eva ;

Parish, Marie ;

Bajor, David L. ;

Ruggeri, Antony ;

Tolay, Sameer ;

Conces, Madison ;

Lumish, Melissa Amy ;

Mohamed, Amr ;

Mahipal, Amit ;

Shreenivas, Aditya V. .

JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) :736-736

[29] Antitumor activity of dostarlimab in patients with mismatch repair-deficient/microsatellite instability-high tumors: A combined analysis of two cohorts in the GARNET study. [J].

Berton, Dominique ;

Banerjee, Susana N. ;

Curigliano, Giuseppe ;

Cresta, Sara ;

Arkenau, Hendrik-Tobias ;

Abdeddaim, Cyril ;

Kristeleit, Rebecca Sophie ;

Redondo, Andres ;

Leath, Charles A. ;

Torres, Antonio Anton ;

Guo, Wei ;

Im, Ellie ;

Andre, Thierry .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[30] Iparomlimab (QL1604) in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) unresectable or metastatic solid tumors: a pivotal, single-arm, multicenter, phase II trial [J].

Bi, Feng ;

Dong, Jian ;

Jin, Chuan ;

Niu, Zuoxing ;

Yang, Wenhui ;

He, Yifu ;

Yu, Dajun ;

Sun, Meili ;

Wang, Teng ;

Yin, Xianli ;

Zhang, Ruixing ;

Chen, Kehe ;

Wang, Keming ;

Wang, Zhiwu ;

Li, Wei ;

Zhang, Zhongtao ;

Zhang, Hangyu ;

Guo, Qunyi ;

Wang, Xin ;

Han, Lei ;

Zhang, Xizhi ;

Shen, Wei ;

Zhang, Liangming ;

Ying, Jieer ;

Wu, Miao ;

Hu, Weiguo ;

Li, Zeng ;

Li, Xiaofen ;

Feng, Wenlei ;

Zhang, Baihui ;

Li, Lingyan ;

Kang, Xiaoyan ;

Guo, Weijian .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)

← 1 2 3 4 5 →